Call 800 665 0411 to learn about our services

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

#Cannabisstocks: Beleave (CSE: BE) (OTCQX: BLEVF) Expands its Global Footprint into #Colombia


TORONTO - June 21, 2018 ( Newswire) Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has acquired 51% of Procannmed S.A.S. ("Procannmed"), a privately held company that is fully licensed for the cultivation, production, extraction and distribution of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis in Colombia. The other 49% ownership was retained by the Colombian based operator ITRUST HOLDINGS S.A.S ("ITRUST"). These licenses enable the propagation of the full range of cannabis varieties and further enable Procannmed to develop a complete offering of standardized, medicinal-grade formulations.

Beleave acquired 51% of Procannmed for a combination of cash ($900,000) and Beleave common shares ($1,500,000 value) for a total purchase price of $2,400,000. The transaction stemmed from a lengthy due diligence process in which members of the Beleave team visited Colombia to speak with Procannmed representatives and various government and industry-related parties.

"We have been conducting extensive market research in various parts of the world and see Colombia as a tremendous growth opportunity," commented Beleave CEO, Andrew Wnek. "Global cannabis prohibition is coming to an end and we plan to capitalize on this in multiple jurisdictions of interest. Colombia in particular provides regulatory support and an outstanding, competitive cost structure making it an attractive destination for foreign investment."

Procannmed is well-positioned to capitalize on the expanding medical needs of over 620 million people in Latin America, with 68 million potential patients identified by other companies in the region. It currently has the ability to grow biomass and extract from their 965,000 sq ft grow space at its property located in the municipality of Argelia in the region of Antioquia.

Further, the companies have together identified other large-scale production properties and have laid out an aggressive plan to have the largest production facility in Colombia. Procannmed has registered 23 high-potency THC strains and one 19.6% CBD/0.03% THC strain with Instituto Colombiano Agropecuario (ICA).

"We are delighted to have reached an agreement with Beleave," said Alberto Jose Esmeral Ramirez, President of ITRUST. "This is an exciting time in the cannabis industry, and Colombia offers a special opportunity thanks in part to unprecedented government support as the country aims to become one of the largest global exporters."

Both Beleave and ITRUST plan on renaming Procannmed with an overhaul of the branding initiative to be established by both companies in tandem.

About Beleave Inc.

Beleave is a biotech company who's wholly-owned subsidiary Beleave Kannabis Corp. is licensed to cultivate and sell medical cannabis and produce cannabis oils and extracts pursuant to Health Canada's Access to Cannabis for Medical Purpose Relations. Beleave has developed a network of medical cannabis clinics under the Medi-Green banner and has applied for various patents to broaden its strong research focused foundation.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on

SOURCE: Beleave Inc.

For further information:

Sebastian de Kloet, Phone: (905) 979 - 5173, Email:;

Richard Oyelowo, Phone: (416) 712 - 9402, Email:

Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

At and

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits